To study the antiproliferative response of B cells to interferon-alpha (IFN-alpha) at the molecular level, we developed a cell-free system to assess DNA synthesis in nuclei isolated from IFN-sensitive Daudi B lymphoblastoid cells. [3H]dTTP incorporation in isolated nuclei was shown to be representative of replicative DNA synthesis by evidence that (i) incorporation was dependent on ATP and all four nucleoside precursors, (ii) incorporation was inhibited greater than 97% by aphidicolin, a specific inhibitor of DNA polymerase alpha and delta, and (iii) the DNase I-sensitive product banded in neutral CsCl at a density indicative of replicative DNA. This cell-free model was used in conjunction with flow cytometric cell cycle analysis to determine the effect of IFN-alpha on DNA synthesis in Daudi cells. The addition of IFN-alpha to an IFN-growth sensitive Daudi subclone in G0/early G1 inhibited the initiation of DNA synthesis, assessed in isolated nuclei, and prevented the progression of cells into S phase. IFN-alpha failed to inhibit DNA synthesis or cell cycle progression when added to IFN-sensitive Daudi cells in late G1/early S phase or to an IFN-resistant Daudi subclone. These studies suggest that IFN-alpha inhibits DNA replication and cellular proliferation in Daudi B cells by interfering with G1 cell cycle events.
No takes yet. Share an insight, caveat, or question.
Scarozza et al. (1992) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: